Search Results - "Kim, Bong Seog"

Comparative efficacy and safety of fimasartan in patients with hypertension: A network meta‐analysis of randomized controlled trials by Seo, Suk Min, Ihm, Sang Hyun, Yi, Jeong‐Eun, Jeong, Seung Hee, Kim, Bong‐Seog

“…Hypertension is a prevalent risk factor for cardiovascular disease. Angiotensin II receptor blockers are widely prescribed to patients with hypertension, while…”
Get full text

A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer by Kang, Jin-Hyoung, Lee, Ki-Hyeong, Kim, Dong-Wan, Kim, Sang-We, Kim, Hye Ryun, Kim, Joo-Hang, Choi, Jin-Hyuk, An, Ho Jung, Kim, Jin-Soo, Jang, Joung-Soon, Kim, Bong-Seog, Kim, Heung Tae

“…Background This study compared the efficacy/safety of the camptothecin analogues belotecan and topotecan for sensitive-relapsed small-cell lung cancer (SCLC)…”
Get full text

Gefitinib Versus Pemetrexed as Second-Line Treatment in Patients With Nonsmall Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy (KCSG-LU08-01): An Open-Label, Phase 3 Trial by SUN, Jong-Mu, KI HYEONG LEE, IN GYU HWANG, LEE, Keehyun, SOOK JUNG JO, JAE WON LEE, JIN SEOK AHN, PARK, Keunchil, AHN, Myung-Ju, KIM, Sang-We, DAE HO LEE, YOUNG JOO MIN, HWAN JUNG YUN, HOON KYO KIM, HONG SUK SONG, YEUL HONG KIM, KIM, Bong-Seog

“…Gefitinib was compared with pemetrexed as second-line therapy in a clinically selected population previously treated with platinum-based chemotherapy. A phase…”
Get full text

Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive‐stage disease small cell lung cancer: Results from a randomized controlled trial by Lee, Gyeong‐Won, Go, Se‐Il, Kim, Dong‐Wan, Kim, Hoon‐Gu, Kim, Joo‐Hang, An, Ho Jung, Jang, Joung Soon, Kim, Bong‐Seog, Hahn, Seokyung, Heo, Dae Seog

“…Background Clinical impact of the Geriatric Nutritional Risk Index (GNRI) in patients with extensive‐stage disease small cell lung cancer (ED‐SCLC) have not…”
Get full text

Prediction of Two-Year Recurrence-Free Survival in Operable NSCLC Patients Using Radiomic Features from Intra- and Size-Variant Peri-Tumoral Regions on Chest CT Images by Lee, Soomin, Jung, Julip, Hong, Helen, Kim, Bong-Seog

“…To predict the two-year recurrence-free survival of patients with non-small cell lung cancer (NSCLC), we propose a prediction model using radiomic features of…”
Get full text

Practice patterns of multidisciplinary team meetings in Korean cancer care and patient satisfaction with this approach by Maeng, Chi Hoon, Ahn, Hee Kyung, Oh, Sung Yong, Lim, Seungtaek, Kim, Bong-Seog, Kim, Do Yeun

“…The multidisciplinary team (MDT) approach is a cornerstone of clinical oncology. This study investigated the current state of MDT care, including patient…”
Get full text

Efficacy and safety of oxycodone/naloxone as add‐on therapy to gabapentin or pregabalin for the management of chemotherapy‐induced peripheral neuropathy in Korea by Kim, Bong‐Seog, Jin, Jong‐Youl, Kwon, Jung Hye, Woo, In Sook, Ko, Yoon Ho, Park, Suk‐Young, Park, Hye‐Jeong, Kang, Jin Hyung

“…Aims To investigate the efficacy and safety of oxycodone/naloxone in patients with chemotherapy‐induced peripheral neuropathy (CIPN) inadequately controlled…”
Get full text

Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives by Koh, Su-Jin, Kim, Shinmi, Kim, JinShil, Keam, Bhumsuk, Heo, Dae Seog, Lee, Kyung Hee, Kim, Bong-Seog, Kim, Jee Hyun, Chang, Hye Jung, Baek, Sun Kyung

“…The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL…”
Get full text

Survey of Medical Oncology Status in Korea (SOMOS-K): A National Survey of Medical Oncologists in the Korean Association for Clinical Oncology (KACO) by Kim, Do Yeun, Lee, Yun Gyoo, Kim, Bong-Seog

“…This study was conducted to investigate the current role of medical oncologists in cancer care with a focus on increasing the recognition of medical oncology…”
Get full text

Surrogate decision making of chemotherapy consent: do we really provide informed consent of chemotherapy for patients? by Kwon, Jung Hye, Baek, Sun Kyung, Kim, Bong-Seog, Koh, Su-Jin, Ahn, Hee Kyung, Lim, Joo Han, Lim, Chiyeon, Kim, Do Yeun

“…Despite increased demand for cancer patient's to make their own decisions based on an adequate understanding of what is involved in chemotherapy, the primary…”
Get full text

The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study by Byun, Jae Ho, Ahn, Joong Bae, Kim, Sun Young, Kang, Jung Hun, Zang, Dae Young, Kang, Seok Yun, Kang, Myoung Joo, Shim, Byoung Yong, Baek, Sun Kyung, Kim, Bong-Seog, Lee, Kyung Hee, Lee, Soon Il, Cho, Sang-Hee, Sohn, Byeong Seok, Kim, Samyong, Hwang, In Gyu, Nam, Eun Mi, Seo, Bong-Gun, Oh, Sang Cheul, Lee, Myung-Ah, Lee, Sang-Cheol, Hong, Ji Hyung, Park, Young Suk

“…Colorectal cancer is associated with different anatomical, biological, and clinical characteristics. We determined the impact of the primary tumor location in…”
Get full text

Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement by Lim, Sun Min, Kim, Hye Ryun, Lee, Jong-Seok, Lee, Ki Hyeong, Lee, Yun-Gyoo, Min, Young Joo, Cho, Eun Kyung, Lee, Sung Sook, Kim, Bong-Seog, Choi, Moon Young, Shim, Hyo Sup, Chung, Jin-Haeng, La Choi, Yoon, Lee, Min Jeong, Kim, Maria, Kim, Joo-Hang, Ali, Siraj M, Ahn, Myung-Ju, Cho, Byoung Chul

“…Purpose ROS1 rearrangement is a distinct molecular subset of non-small-cell lung cancer (NSCLC). We investigated the efficacy and safety of ceritinib in…”
Get full text

BNP as a marker of the heart failure in the treatment of imatinib mesylate by Park, Yeon Hee, Park, Hae Jeong, Kim, Bong-Seog, Ha, Eunyoung, Jung, Kyung Hee, Yoon, Seo Hyun, Yim, Sung Vin, Chung, Joo-Ho

“…Since its introduction 6 years ago, imatinib mesylate, a selective tyrosine kinase inhibitor, has been a phenomenon in treating chronic myelogenous leukemia…”
Get full text

Enhancing Two-Year Recurrence-Free Survival Prediction in Non-Small Cell Lung Cancer (NSCLC) Patients Using Tumor-Centric Attention Network (TCA-Net) by Kim, Hye Ryun, Ahn, Gahee, Hong, Helen, Kim, Bong-Seog

“…Purpose Accurate predictions of postoperative recurrence are essential for determining appropriate follow-up treatments after surgery, as patients with…”
Get full text

Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study by Lee, Ji Heui, Kang, Seok Hee, Kim, Yunkwang, Kim, Hyun Ah, Kim, Bong Seog

“…The optimal combination of anesthetic agent and technique may have an influence on long-term outcomes in cancer surgery. In vitro and in vivo studies suggest…”
Get full text

A Multiple Mobility Support Approach (MMSA) based on PEAS for NCW in wireless sensor networks by Koo, Bong-Joo, Kim, Seog-Bong, Park, Jong-Yil, Park, Kang-Min

“…Wireless Sensor Networks (WSNs) can be implemented as one of sensor systems in Network Centric Warfare (NCW). Mobility support and energy efficiency are key…”
Get full text

Lung tumor segmentation using dual-coupling net with shape prior based on lung and mediastinal window images from chest CT images by Byun, Sohyun, Jung, Julip, Hong, Helen, Kim, Bong-Seog

“…Volumetric lung tumor segmentation is difficult due to the diversity of the sizes, locations and shapes of lung tumors, as well as the similarity in the…”
Get more information

Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16) by Park, Inkeun, Kim, Bong-Seog, Lim, Ho Yeong, Kim, Hee-Jun, Lee, Hyo Jin, Choi, Yoon Ji, Park, Kyong Hwa, Lee, Kyung Hee, Yoon, Shinkyo, Hong, Bumsik, Hong, Jun Hyuk, Ahn, Hanjong, Lee, Jae Lyun

“…Gemcitabine–oxaliplatin (GEMOX) demonstrated mild toxicity and promising effectiveness in patients with advanced urothelial cell cancer (UCC). We investigated…”
Get full text

Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07) by Sun, Jong-Mu, Lee, Ki Hyeong, Kim, Bong-Seog, Kim, Hoon-Gu, Min, Young Joo, Yi, Seong Yoon, Yun, Hwan Jung, Jung, Sin-Ho, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju

“…Background: We investigated whether pazopanib maintenance following first-line chemotherapy would improve survival in patients with extensive disease…”
Get full text

A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy by Lee, Hee Yeon, Kim, Hoon-Kyo, Lee, Kyung Hee, Kim, Bong-Seog, Song, Hong Suk, Yang, Sung Hyun, Kim, Joon Hee, Kim, Yeul Hong, Kim, Jong Gwang, Kim, Sang-We, Kim, Dong-Wan, Kim, Si-Young, Park, Hee Sook

“…This study was conducted to evaluate the efficacy and safety of azasetron compared to ondansetron in the prevention of delayed chemotherapy-induced nausea and…”
Get full text